What 507 U.S. physicians just told us about peptide therapies should be on every commercial and medical affairs team's radar. In our latest Sermo Barometer: 48% say patients are already using non-FDA-approved peptides 84% report social media is shaping what patients ask for 69% expect GLP-3s to drive the next wave of demand Markets shift fast. Physician perspective shifts faster. Sermo's HCP Insights Research Solutions capture the voice of the physician at scale, across 150+ countries and every specialty, so you can act on what's coming, not just what's here. See how we help clients stay ahead: https://bit.ly/3TiqyRn #HCPInsights #MarketResearch #LifeSciences #PhysicianVoice
Sobre nosotros
Sermo turns physician experience, expertise, and observations into actionable insights for the global healthcare community. Engaging with more than 1 million HCPs across 150 countries, we provide physicians with a social platform and unique community that fosters impactful peer-to-peer collaboration & discussions about issues that are important to them and their patients. Sermo offers on demand access to physicians via a suite of proprietary technology to provide business intelligence that benefits patients, pharmaceutical, healthcare partners and the medical community at large. Doctors and other HCPs can sign up today at https://sermo.link/sign-up-li
- Sitio web
-
http://www.sermo.com
Enlace externo para Sermo
- Sector
- Desarrollo de software
- Tamaño de la empresa
- De 501 a 1.000 empleados
- Sede
- New York, NY
- Tipo
- De financiación privada
- Fundación
- 2000
- Especialidades
- Healthcare Fieldwork, Physician Engagement y Market Research
Ubicaciones
Empleados en Sermo
Actualizaciones
-
Peptide demand is accelerating fast, and physicians are seeing it firsthand. 👀 Nearly half of physicians say patients have disclosed using non-FDA-approved peptides in the past 12 months, while 84% say patients are getting peptide information from social media, podcasts, and influencers. See what physicians are saying in Sermo’s latest Barometer: https://bit.ly/4wH5RNr #SermoBarometer #Peptides #HCPInsights
-
-
The peptide debate is no longer a niche conversation. As FDA advisors meet this week to discuss the future of compounded peptides, the industry is grappling with questions around access, safety, evidence, and regulation. The discussion has become one of healthcare's most closely watched topics, and physician perspectives are critical to understanding what is happening on the front lines. That's why we're proud to see Sermo's latest barometer insights featured in STAT. Our survey of 500 physicians sheds light on the growing demand for peptides and the real-world considerations clinicians are navigating every day. 📖 Read the STAT article: https://lnkd.in/eQCwABPH
-
The peptide conversation is HEATING UP. 66% of physicians are concerned about patients accessing investigational peptides outside supervised pathways, and many say unrealistic expectations are becoming one of the biggest challenges in patient conversations. Explore the latest findings from Sermo’s Barometer 45: Emerging Peptide Therapies https://bit.ly/4wH5RNr #SermoBarometer #Peptides #HCPInsights
-
-
⭐ Sermo has been recognized as one of America’s Best Online Platforms by Newsweek ⭐ This ranking names organizations delivering trusted, high-quality digital experiences based on user feedback, usability and performance; find us in the Health & Care Category with other leading health-focused platforms. Every day, physicians globally log on to Sermo to exchange insights, learn from their peers, and stay informed. We're so proud to provide a community that supports those conversations. Learn more: https://bit.ly/3R4Dp8X #Sermo #PhysicianCommunity
-
-
When it comes to solutions (and friendly competition!), we can’t stop, won’t stop so swing by for delicious drinks at Association of Medical Media's Sports Day. Whether you’re playing a round of golf or relaxing by the pool, this is self-care we can get behind; then, the group comes together in the evening to support the Foundation for Sarcoidosis Research. Feel good, do good – that’s an event we’re proud to support. https://lnkd.in/gNbhxftp #AMMSportsDay #Sermo
-
-
Combating Misinformation and Building Your Digital Presence in the Age of AI. Join us for a live physician‑led webinar exploring how AI is accelerating health misinformation and impersonation online, and how to build a credible digital presence, hosted by Dr. Eleonora Teplinsky, MD, FASCO and Dr. Shikha Jain, MD, FACP. 📅 July 20th | 3:15–4:00pm ET 📍 Live on Sermo Save your spot: https://bit.ly/3SPrUmE
-
-
We couldn’t have said it better ourselves. ⬇️ Together with GSK Vaccines Global Medical Affairs, we’re thrilled to share that Sermo is a PM Society #PMiAwards finalist. We’re proud to educate physicians on the critical role that vaccination plays in protecting patients from Invasive Meningococcal Disease. Congratulations to all: https://bit.ly/4pc8uV4 #PMSociety #PMiAwards2026 #PharmaMarketing #Innovation #Healthcare
-
-
Join us for a live, interactive physician-led webinar to debunk common GI myths and how clinicians can tackle patient symptoms, hosted by Dr. Leybelis Padilla, MD FACG. 📅 Thursday, June 25 · 4:30–5:15 PM ET 📍 Live on Sermo Save your spot: https://lnkd.in/gtmi2zfe
-
-
Imagine not being able to recognize the sound of your coffee maker in the morning or a crosswalk signal on the walk home. Driven by Envoy Medical and the power of medical research, watch as a first-of-its-kind technology triumphs over hearing loss: https://lnkd.in/gwyrqUTZ
-